期刊文献+

系统性红斑狼疮患者发生骨质疏松的危险因素及其防治对策 被引量:4

Risk Factors and Prevention Measures for Osteoporosis in Patients with Systemic Lupus Erythematosus
下载PDF
导出
摘要 随着诊断技术及治疗水平的提高,系统性红斑狼疮(SLE)患者的存活率逐渐上升,生活质量也得到极大的改善。骨质疏松症作为SLE常见的并发症之一,不仅影响SLE患者的日常生活,甚至继发严重骨折,而危及患者的生命。糖皮质激素的应用是SLE并发骨质疏松的最常见原因,充分认识SLE患者发生骨质疏松的危险因素,为治疗药物的选择提供理论基础,对于提高患者的生存率及生活质量具有重要作用。该文就SLE患者发生骨质疏松的主要危险因素和防治对策予以综述。 With the improvement of diagnostic techniques and therapeutic levels,the survival of patients with systemic lupus erythematosus ( SLE ) has increased gradually and the quality of life has been greatly improved.Osteoporosis is one of the complications of SLE,affecting the quality of life for patients with SLE and even endangers the life of patients in case of severe fracture.Glucocorticoids usage is the most common cause of osteoporosis in SLE patients.To improve the survival rate and the life of patients with SLE,it is important to study the risk factors of SLE with osteoporosis and provide a theoretical basis for the choice of medication.Here is to make a review of the various risk factors,preventative and therapeutic strategies for os-teoporosis of SLE patients.
出处 《医学综述》 2015年第14期2541-2543,共3页 Medical Recapitulate
关键词 系统性红斑狼疮 骨质疏松 危险因素 防治对策 Systemic lupus erythematosus Osteoporosis Risk factors Preventive and therapeutic measures
  • 相关文献

参考文献25

  • 1李思,邹延峰.系统红斑狼疮应用糖皮质激素致骨质疏松的流行情况及发病机制研究进展[J].安徽医药,2014,18(2):225-229. 被引量:12
  • 2Boyanov M,Robeva R,Popivanov P.Bone mineral density changes in women with systemic lupus erythematosus[J].Clin Rheumatol,2003,22(4/5):318-323.
  • 3Mok CC,Mak A,Ma KM.Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus[J].Lupus,2005,14(2):106-112.
  • 4Steinbuch M,Youket TE,Cohen S.Oral glucocorticoid use is associated with an increased risk of fracture[J].Osteoporos Int,2004,15(4):323-328.
  • 5臧银善,刘晓华,张缪佳.系统性红斑狼疮并发骨坏死的相关因素分析[J].中国医刊,2007,42(1):46-49. 被引量:10
  • 6Suzuki Y,Sato S.Secondary osteoporosis UPDATE.Clinical significance glucocorticoid-induced osteporosis[J].Clin Calcium,2010,20(5):645-653.
  • 7Ruiz-Irastorza G,Danza A,Khamashta M.Glucocorticoid use and abuse in SLE[J].Rheumatology(Oxford),2012,51(7):1145-1153.
  • 8Pereira RM,Carvalho JF,Canalis E.Glucocorticoid-induced osteoporosis in rheumatic diseases[J].Clinics(Sao Paulo),2010,65(11):1197-1205.
  • 9Coimbra IB,Costallat LT.Bone mineral density in systemic lupus erythematosus and its relation to age at disease onset,plasmatic estradiol and immunosupressive therapy[J].Joint Bone Spine,2003,70(1):40-45.
  • 10Uaratanawong S,Deesomchoke U,Lertmaharit S,et al.Bone mineral density-4-in premenopausal women with systemic lupus erythematosis[J].J Rheumatol,2003,30(11):2365-2368.

二级参考文献108

共引文献31

同被引文献45

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部